Search Results - "PRIMDAHL, Hanne"
-
1
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
Published in Radiotherapy and oncology (01-12-2014)“…Abstract Background and purpose HPV is found in head and neck cancer from all sites with a higher prevalence in oropharynx cancer (OPC) compared to non-OPC…”
Get full text
Journal Article -
2
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV‐positive oropharynx cancer: Large‐scale comparison of DAHANCA vs PMH cohorts
Published in International journal of cancer (15-04-2022)“…We compare outcomes in two large‐scale contemporaneously treated HPV‐positive (HPV+) oropharynx cancer (OPC) cohorts treated with definitive…”
Get full text
Journal Article -
3
Evaluation of comorbidity in 9388 head and neck cancer patients: A national cohort study from the DAHANCA database
Published in Radiotherapy and oncology (01-01-2014)“…Abstract Background Comorbidity is common in head and neck squamous cell carcinoma (HNSCC) patients due to the etiology of the disease being primarily smoking…”
Get full text
Journal Article -
4
Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy – Results from the randomized DAHANCA 25B trial
Published in Radiotherapy and oncology (01-08-2013)“…Abstract Purpose The critical weight loss observed in head and neck squamous cell carcinoma (HNSCC) patients following radiotherapy is mainly due to loss of…”
Get full text
Journal Article -
5
Salivary gland carcinoma in Denmark 1990–2005: A national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)
Published in Oral oncology (01-07-2011)“…Summary To describe the incidence, site and histology (WHO 2005) of salivary gland carcinomas in Denmark. Nine hundred and eighty-three patients diagnosed from…”
Get full text
Journal Article -
6
Salivary adenoid cystic carcinoma in Denmark 1990–2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)
Published in Oral oncology (01-12-2015)“…Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced…”
Get full text
Journal Article -
7
Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial
Published in BMC cancer (03-06-2017)“…Head and neck cancer patients undergoing concomitant chemoradiotherapy (CCRT) frequently experience loss of muscle mass and reduced functional performance…”
Get full text
Journal Article -
8
The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database
Published in Acta oncologica (01-02-2013)“…Head and neck squamous cell carcinoma (HNSCC) is primarily caused by smoking and alcohol. Besides having a carcinogenic effect, smoking also leads to other…”
Get more information
Journal Article -
9
Salivary duct carcinoma: a Danish national study
Published in Journal of oral pathology & medicine (01-10-2016)“…Background To present the first national series of salivary duct carcinoma patients, including survival rates and an analysis of prognostic factors. Methods By…”
Get full text
Journal Article -
10
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
Published in Acta oncologica (02-09-2018)“…To study the associations between development of moderate to severe skin rash, clinical outcome, and single nucleotide polymorphisms (SNPs) in candidate genes…”
Get more information
Journal Article -
11
High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma – A DAHANCA 19 study
Published in Clinical and translational radiation oncology (01-05-2024)“…•The majority (80 %) of loco-regional failures in HNSCC arise within high-dose volume.•Treatment failure in HNSCC is in most cases due to tumor…”
Get full text
Journal Article -
12
A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome
Published in Clinical cancer research (01-06-2005)“…Purpose: Cancer of the urinary bladder is a common malignant disease in the western countries. The majority of patients presents with superficial tumors with a…”
Get full text
Journal Article -
13
Oncocytic carcinoma of the salivary glands: A Danish national study
Published in Auris, nasus, larynx (01-08-2018)“…To present a Danish national series of oncocytic carcinoma (OC) patients, including data on treatment, recurrence and survival. From the national Danish…”
Get full text
Journal Article -
14
Salivary gland carcinomas of the larynx: A national study in Denmark
Published in Auris, nasus, larynx (01-12-2012)“…Abstract Objective Salivary gland carcinomas of the larynx are rare. The purpose of this study is to present a national series of laryngeal salivary gland…”
Get full text
Journal Article -
15
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer
Published in Oncogene (04-11-2004)“…Checkpoint kinase 2 (Chk2) is a tumour suppressor and signal transducer in genome integrity checkpoints that coordinate cell-cycle progression with DNA repair…”
Get full text
Journal Article -
16
Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas
Published in Molecular & cellular proteomics (01-04-2002)“…Proteomics and immunohistochemistry were used to reveal tumor heterogeneity among urothelial papillomas (UPs) with the long term goal of predicting their…”
Get full text
Journal Article -
17
1118: Unilateral treatment of lateralised oral cavity and pharynx squamous cell carcinomas
Published in Radiotherapy and oncology (01-05-2024)Get full text
Journal Article -
18
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study
Published in Acta oncologica (01-07-2015)“…A phase II clinical trial evaluating the feasibility and outcome of treating locally advanced head and neck squamous cell carcinoma (HNSCC) with accelerated…”
Get more information
Journal Article -
19
2472: The effect of primary radiotherapy in oropharynx cancer: A phase IV population-based DAHANCA study
Published in Radiotherapy and oncology (01-05-2024)Get full text
Journal Article -
20
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial
Published in Radiotherapy and oncology (01-10-2012)“…Abstract Purpose Hypoxia is a cause of resistance to radiotherapy, especially in patients with head and neck squamous cell carcinoma (HNSCC). The purpose of…”
Get full text
Journal Article